Country: Portugal
Language: English
Source: HMA (Heads of Medicines Agencies)
marbofloxacin 100 mg/ml
Miklich Laboratorios S.L
QJ01MA93
Solution for injection
marbofloxacin
Cattle, Pigs
2011-03-23
Revised: September 2012 AN: 01598/2011 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERSITICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Ubiflox 100 mg/ml Solution for Injection for Cattle and Pigs (Sows) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of solution for injection contains: ACTIVE SUBSTANCE: Marbofloxacin 100 mg EXCIPIENTS: Disodium edetate 0.10 mg Monothioglycerol 1 mg Metacresol 2 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. Clear, greenish yellow to brownish yellow solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and pigs (sows). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES CATTLE Treatment of respiratory infections caused by sensitive strains of _Pasteurella _ _multocida_, _Mannheimia haemolytica,_ _Mycoplasma bovis_ and _Histophilus somni_. Treatment of acute mastitis caused by _Escherichia coli_ strains sensitive to marbofloxacin during the lactation period. SOWS Treatment of Metritis Mastitis Agalactia Syndrome (postpartum dysgalactiae syndrome, PDS) caused by bacterial strains sensitive to marbofloxacin. 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active substance or to any of the excipients. Do not use in cases where the pathogen involved is resistant to other fluoroquinolones (cross resistance). Revised: September 2012 AN: 01598/2011 Page 2 of 6 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FO Read the complete document